Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Marine Scotland has rejected GlaxoSmithKline's proposal to install tidal turbine at its ingredient manufacturing plant in Montrose, Scotland on the grounds that the project might have damaged the sensitive site.
Subscribe to our email newsletter
The rejection follows the company’s previously dismissed proposal to install wind turbines at the facility.
The company, which has accepted the decision, is working with Marine Scotland to evaluate the bladeless tidal turbines feasibility, reports FiercePharmaManufacturing citing Montrose Review.
GSK aims to achieve its target using 5 MW from wind, 0.66 MW from tidal and 1.15 MW from a combined heat and power plant, according to the news agency.